The growth in the preclinical imaging market is driven by the increasing funding to support preclinical research, development of low-cost & affordable preclinical imaging systems, and increasing market demand for new drug development and non-invasive small-animal imaging techniques. Download an Illustrative overview: Browse in-depth TOC on "Preclinical Imaging Market" 83 - Tables 40 - Figures 165 - Pages Preclinical Imaging Market Scope: Report Coverage Details Market Revenue in 2024 $946 million Estimated Value by 2029 $1,259 million Growth Rate Poised to grow at a CAGR of 5.9% Market Size Available for 2018–2029 Forecast Period 2024–2029 Forecast Units Value (USD Million) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered Product Type, Application, End User, and Region Geographies Covered North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, And Rest of Latin America), and Middle East & Africa (GCC Countries, and Rest of MEA) Report Highlights Updated financial information / product portfolio of players Key Market Opportunities Increasing Adoption of Imaging Systems for Preclinical Purposes Key Market Drivers Increasing market demand for non-invasive small animal imaging techniques Optical Imaging reagents segment is the largest product type of the preclinical reagents market in 2023.

.